Blood Reviews
Volume 22 , Pages S22-S28 , December 2008

The role of iron in patients after bone marrow transplantation

  • Theo de Witte

      Affiliations

    • Corresponding Author InformationTheo de Witte. Radboud University Nijmegen, Medical Centre Central, route 476, 576 Dept. of Hematology, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. Tel.: +31 (0)24 361 8810; fax: +31 (0)24 354 2080

References 

  1. Gordon LI , Brown SG , Tallman MS , et al.   Sequential changes in serum iron and ferritin in patients undergoing high-dose chemotherapy and radiation with autologous bone marrow transplantation: possible implications for treatment related toxicity . Free Radic Biol Med . 1995;18:383–389
  2. Dürken M , Nielsen P , Knobel S , et al.   Nontransferrin-bound iron in serum of patients receiving bone marrow transplants . Free Radic Biol Med . 1997;22:1159–1163
  3. Sahlstedt L , Ebeling F , von Bonsdorff L , et al.   Nontransferrin-bound iron during allogeneic stem cell transplantation . Br J Haematol . 2001;113:836–838
  4. Dürken M , Herrnring C , Finckh B , et al.   Impaired plasma antioxidant defense and increased nontransferrin-bound iron during high-dose chemotherapy and radiochemotherapy preceding bone marrow transplantation . Free Radic Biol Med . 2000;28:887–894
  5. Butt NM , Clark RE . Autografting as a risk factor for persisting iron overload in long-term survivors of acute myeloid leukaemia . Bone Marrow Transplant . 2003;32:909–913
  6. Gaziev J , Sodani P , Polchi P , et al.   Bone marrow transplantation in adults with thalassemia. Treatment and long-term follow-up . Ann NY Acad Sci . 2005;1054:196–205
  7. Malcovati L , Porta MG , Pascutto C , et al.   Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making . J Clin Oncol . 2005;23:7594–7603
  8. Cappellini DM , Tavazzi D , Duca L , Marelli S , Fiorelli G . Non-transferrin-bound iron, iron-related oxidative stress and lipid peroxidation in beta-thalassemia intermedia . Transfus Sci . 2000 Dec;23(3):245–246
  9. Cortelezzi A , Cattaneo C , Cristiani S , et al.   Nontransferrin-bound iron in myelodysplastic syndromes: a marker of ineffective erythropoiesis? . Hematol J . 2000;1:153–158
  10. Tanno T , Bhanu NV , Oneal PA , et al.   High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin . Nat Med . 2007;13:1096–1101
  11. Evens AM , Mehta J , Gordon LI . Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stress . Bone Marrow Transplant . 2004;34:561–571
  12. Clemens MR , Ladner C , Schmidt H , et al.   Decreased essential antioxidants and increased lipid hydroperoxides following high-dose radiochemotherapy . Free Radic Biol Med . 1989;7:227–232
  13. Dürken M , Agbenu J , Finckh B , et al.   Deteriorating free radical-trapping capacity and antioxidant status in plasma during bone marrow transplantation . Bone Marrow Transplant . 1995;15:757–762
  14. Hunnisett A , Davies S , McLaren-Howard J , et al.   Lipoperoxides as an index of free radical activity in bone marrow transplant recipients. Preliminary observations . Biol Trace Elem Res . 1995;47:125–132
  15. Wayner DD , Burton GW , Ingold KU , et al.   The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma . Biochim Biophys Acta . 1987;924:408–419
  16. Miceli MH , Dong L , Grazziutti ML , et al.   Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: a study of 367 myeloma patients . Bone Marrow Transplant . 2006;37:857–864
  17. Altes A , Remacha AF , Sarda P , et al.   Early clinical impact of iron overload in stem cell transplantation. A prospective study . Ann Hematol . 2007;86:443–447
  18. Altes A , Remacha AF , Sarda P , et al.   Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosis . Bone Marrow Transplant . 2004;34:505–509
  19. Schaible UE , Kaufmann SH . Iron and microbial infection . Nat Rev Microbiol . 2004;2:946–953
  20. Blijlevens NM , Donnelly JP , De Pauw BE . Mucosal barrier injury: biology, pathology, clinical counterparts andcon-sequences of intensive treatment for haematological malignancy: an overview . Bone Marrow Transplant . 2000;25:1269–1278
  21. Pullarkat V , Blanchard S , Tegtmeier B , et al.   Iron overload adversely affects survival and increases risk of graft-versus-host disease and blood stream infections after allogeneic hematopoietic stem cell transplantation . Blood . 2007;110: abstract 2981.
  22. Tomas JF , Pinilla I , Garcia-Buey ML , et al.   Long-term liver dysfunction after allogeneic bone marrow transplantation: clinical features and course in 61 patients . Bone Marrow Transplant . 2000;26:649–655
  23. Iqbal M , Creger RJ , Fox RM , et al.   Laparoscopic liver biopsy to evaluate hepatic dysfunction in patients with hematologic malignancies: a useful tool to effect changes in management . Bone Marrow Transplant . 1996;17:655–662
  24. McKay PJ , Murphy JA , Cameron S , et al.   Iron overload and liver dysfunction after allogeneic or autologous bone marrow transplantation . Bone Marrow Transplant . 1996;17:63–66
  25. Harrison P , Neilson JR , Marwah SS , et al.   Role of non-transferrin bound iron in iron overload and liver dysfunction in long term survivors of acute leukaemia and bone marrow transplantation . J Clin Pathol . 1996;49:853–856
  26. Angelucci E , Muretto P , Nicolucci A , et al.   Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation . Blood . 2002;100:17–21
  27. Azar N , Valla D , Abdel-Samad I , et al.   Liver dysfunction in allogeneic bone marrow transplantation recipients . Transplantation . 1996;62:56–61
  28. Lee JL , Gooley T , Bensinger W , et al.   Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcome . Biol Blood Marrow Transplant . 1999;5:306–315
  29. Litzow MR , Pérez WS , Klein JP , et al.   Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide-total body irradiation versus busulphan-cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission . Br J Haematol . 2002;119:1115–1124
  30. Morado M , Ojeda E , Garcia-Bustos J , et al.   Serum ferritin as risk factor for veno-occlusive disease of the liver. Prospective cohort study . Hematology . 2000;2:505–512
  31. Kallianpur AR , Hall LD , Yadav M , et al.   The hemochromatosis C282Y allele: a risk factor for hepatic veno-occlusive disease after hematopoietic stem cell transplantation . Bone Marrow Transplant . 2005;35:1155–1164
  32. Clark JG , Hansen JA , Hertz MI , et al.   NHLBI workshop summary. Idiopathic pneumonia syndrome after bone marrow transplantation . Am Rev Respir Dis . 1993;147:1601–1606
  33. Fukuda T , Hackman RC , Guthrie KA , et al.   Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation . Blood . 2003;102:2777; 2285
  34. Kantrow SP , Hackman RC , Boeckh M , et al.   Idiopathic pneumonia syndrome: changing spectrum of lung injury after marrow transplantation . Transplantation . 1997;63:1079–1086
  35. Wong R , Rondon G , Saliba RM , et al.   Idiopathic pneumonia syndrome after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for high-risk breast cancer . Bone Marrow Transplant . 2003;31:1157–1163
  36. Crawford SW , Hackman RC . Clinical course of idiopathic pneumonia after bone marrow transplantation . Am Rev Respir Dis . 1993;147:1393–1400
  37. Balla J , Jacob HS , Balla G , et al.   Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage . Proc Natl Acad Sci USA . 1993;90:9285–9289
  38. Crouch E . Pathobiology of pulmonary fibrosis . Am J Physiol . 1990;259:L159–L184
  39. Lucarelli G , Gaziev J . Advances in the allogeneic transplantation for thalassemia . Blood Rev . 2008;22:53–63
  40. Lucarelli G , Galimberti M , Polchi P , et al.   Bone marrow transplantation in patients with thalassemia . N Engl J Med . 1990;322:417–421
  41. Armand P , Kim HT , Cutler CS , et al.   Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation . Blood . 2007;109:4586–4588
  42. Altes A , Remacha AF , Sureda A , et al.   Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation . Bone Marrow Transplant . 2002;29:987–989
  43. Mahindra A , Bolwell B , Sobecks R , et al.   Elevated pretransplant serum ferritin in autologus stem cell transplant . Blood . 2007;110: abstract 606.
  44. Mahindra A , Bolwell B , Sobecks R , et al.   Prognostic impact of elevated pretransplant serum ferritin in allogeneic hematopoietic stem cell transplantation . Blood . 2007;110: abstract 1109.
  45. Mahindra A , Sobecks R , Rybicki L , et al.   Elevated ferritiin is associated with poorer survival following nonablative allogeneic transplantation . Blood . 2007;110: abstract 1986.
  46. Au WY , Lam WM , Chu WC , et al.   A magnetic resonance imaging study of iron overload in haemopoietic stem cell transplant recipients with increased ferritin levels . Transplant Proc . 2007;39:3369–3374
  47. Takatoku M , Uchiyama T , Okamoto S , et al.   Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anaemia highlights the negative impact of iron overload on morbidity/mortality . Eur J Haematol . 2007;78:487–494
  48. Leitch HA . Improving clinical outcome in patients with myelodysplastic syndrome and iron overload using iron chelation therapy . Leuk Res . 2007;31(Suppl 3):S7–S9
  49. Rose C , Brechignac S , Vassilief D , et al.   Positive impact of iron chelation therapy (CT) on survival in regularly transfused MDS patients. A prospective analysis by the GFM . Blood . 2007;110: abstract 249.
  50. Angelucci E , Muretto P , Lucarelli G , et al.   Phlebotomy to reduce iron overload in patients cured of thalassemia by bone marrow transplantation . Blood . 1997;90:994–998
  51. Li CK , Lai DH , Shing MMK , et al.   Early iron reduction programme for thalassaemia patients after bone marrow transplantation . Bone Marrow Transplant . 2000;25:653–656
  52. Strasser SI , Kowdley KV , Sale GE , et al.   Iron overload in bone marrow transplant recipients . Bone Marrow Transplant . 1998;22:167–173

PII: S0268-960X(08)70005-5

doi: 10.1016/S0268-960X(08)70005-5

Blood Reviews
Volume 22 , Pages S22-S28 , December 2008

Article Tools